NeuOrphan Revenue
Biotechnology Research • • 1-10 Employees
$
NeuOrphan revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at NeuOrphan
Bernard D. Cambou
Advisor to Board of Directors
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
About NeuOrphan
NeuOrphan is developing a drug, currently in the preclinical stage of development, that aims to protect the central nervous system from inflammatory damage and promote repair through remyelination - addressing the unmet medical need in patients living with multiple sclerosis progression.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
NeuOrphan has never raised funding before.
Netherlands
United Kingdom
Frequently asked questions
NeuOrphan is located in XX.
NeuOrphan generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
NeuOrphan has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
NeuOrphan has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
